Krishna Institute of Medical Sciences: The Company ahs acquired 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP (Sangli)
Krishna Institute of Medical Sciences (KIMS) filed a disclosure titled "The Company ahs acquired 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP (Sangli)". The company is valued at about ₹29,505 crore.
What happened
Krishna Institute of Medical Sciences (KIMS) filed a disclosure with the exchanges on 29 October 2026 at 10:59 PM titled "The Company ahs acquired 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP (Sangli)".
How big is it?
At ₹15 crore, the deal is equal to about 0.1% of the company's market value of ₹29,505 crore.
Company snapshot
Krishna Institute of Medical Sciences is a small-cap company in the Healthcare sector, with a market value of about ₹29,505 crore.
The stock last traded at ₹702.5, against a 52-week range of ₹575.8–₹858 (18.1% below the high).
Before this filing the shares had moved −8.1% over the month and −12.7% over three months. Average daily turnover over the last 20 sessions was about ₹38.07 crore.
Promoters held 32.50% at the end of Q1 FY27; 10.26% of promoter shares were pledged. Foreign institutions owned 14.74% and domestic institutions 34.43%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 872 | 78.6 | 1.96 |
| Q2 FY26 | 961 | 67.1 | 1.67 |
| Q3 FY26 | 998 | 53.4 | 1.33 |
| Q4 FY26 | 1,075 | 42.5 | 1.06 |
| Q1 FY27 | 1,180 | 41.5 | 1.04 |
What history shows
This is not the company's first m&a disclosure: BCEIE has 6 earlier filings of this kind on record since May 2026.
After those filings, the stock fell 0.3% on average the next trading day and was up 0.3% on average after five days (5 filings with price data).
Across 150 similar disclosures by other Healthcare companies, shares moved +0.8% on average the next day and +0.9% over five days; 59% of them rose the next day.
Market-wide, 2,219 m&a filings with an impact score of 50 or more saw an average next-day move of +0.3%, with 49% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 6 Oct 2026 | M&A | −0.9% | −0.1% |
| 6 Oct 2026 | Intimation u/r 30-acquistion of upto 51 % stake in Insignia | −0.9% | −0.1% |
| 6 Oct 2026 | M&A | −0.9% | −0.1% |
| 6 Oct 2026 | M&A | −0.9% | −0.1% |
| 26 Aug 2026 | Clarification Regarding Article Appearing In Dealstreetasia.Com… | +2.0% | +1.6% |
What to watch
- Regulatory approvals, completion of the deal and its effect on revenue and margins.
- 4 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- KIMS.NS Slips 1.07% to ₹681.30: Krishna Institute of Medical Sciences Tests Key Support Zone - Channel Projection
- KIMS Legal Update: Chennai Hospital Project Continues Amid Ongoing Land Dispute
- KIMS Analyst Meet at JM Financial India Conference 2026
- KIMS: Expansion Is Still The Story, Empanelments And Debt Now Drive The Upside
- KIMS Chennai Hospital Project: Supreme Court SLP Dismissed
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.